Use of complementary and alternative medicine in children with cancer: Effect on survival

Pediatric Hematology and Oncology

Volumn 29, Issue 4, 2012, Pages 335-344

  Karali, Yasin ^a   Demirkaya, Metin ^a   Sevinir, Betül ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Alternative treatment; Cancer; Children; Complementary medicine

Indexed keywords

ADOLESCENT; ADULT; ALTERNATIVE MEDICINE; ARTICLE; CANCER SURVIVAL; CHILD; DEMOGRAPHY; DIET SUPPLEMENTATION; EDUCATION; FAMILY; FEMALE; FOLLOW UP; HODGKIN DISEASE; HONEY; HUMAN; INFANT; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; NEUROBLASTOMA; NEWBORN; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; PHYSICIAN; PRESCHOOL CHILD; SCHOOL CHILD; SOCIOECONOMICS; SOFT TISSUE SARCOMA; SURVIVAL RATE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMPLEMENTARY THERAPIES; DIETARY SUPPLEMENTS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HONEY; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASMS; PLANTS, MEDICINAL; SURVIVAL RATE; URTICA DIOICA;

EID: 84860850481     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2012.670368     Document Type: Article

References (33)

1. Kelly KM. Bringing evidence to complementary and alternative medicine in children with cancer: focus on nutrition-related therapies. Pediatr Blood Cancer. 2008;50:490-493.
2. National Center for Complementary and Alternative Medicine. What Is Complementary and Alternative Medicine (2002). Available at: http://nccam.nih.gov/health/whatiscam/D156.pdf. Accessed November 24, 2006.
3. Kelly KM. Complementary and alternative medicines for use in supportive care in pediatric cancer. Support Care Cancer. 2007;15:457-460.
4. Kelly KM. Complementary and alternativemedical therapies for children with cancer. Eur J Cancer. 2004;40:2041-2046.
5. Gözüm S, Arikan D, Buyukavci M. Complementary and alternativemedicine use in pediatric oncology patients in eastern Turkey. Cancer Nurs. 2007;30:38-44.
6. Karadeniz C, Pinarli FG, Oguz A, et al. Complementary/alternative medicine use in a pediatric oncology unit in Turkey. Pediatr Blood Cancer. 2007;48:540-543.
7. Samur M, Bozcuk HS, Kara A, et al. Factors associatedwith utilization of nonproven cancer therapies in Turkey: a study of 135 patients from a single center. Support Care Cancer. 2001;9:452-458.
8. Ceylan S, Hamzaoglu O, Komurcu S, et al. Survey of the use of complementary and alternative medicine among Turkish cancer patients. Complement Ther Med. 2002;10:94-99.
9. Risberg T, Vickers A, Bremnes RM, et al. Does use of alternative medicine predict survival fromcancer? Eur J Cancer. 2003;39:372-377.
10. Richardson MA, Russell NC, Sanders T, et al. Assessment of outcomes at alternativemedicine cancer clinics: a feasibility study. J Altern Complement Med. 2001;7:19-32.
11. Sencer SF, Kelly KM. Complementary and alternative therapies in pediatric oncology. Pediatr Clin North Am. 2007;54:1043-1060.
12. McCurdy EA, Spangler JG,WoffordMM,et al. Religiosity is associatedwith the use of complementary medical therapies by pediatric oncology patients. J Pediatr Hematol Oncol. 2003;25:125-129.
13. Faw C, Ballentine R, Ballentine L, et al. Unproved cancer remedies. A survey of use in pediatric outpatients. JAMA. 1977;238:1536-1538.
14. Nathanson I, Sandler E, Ramirez-Garnica G, et al. Factors influencing complementary and alternative medicine use in a multisite pediatric oncology practice. J Pediatr Hematol Oncol. 2007;29:705-708.
15. Fernandez CV, Stutzer CA,MacWilliam L, et al. Alternative and complementary therapy use in pediatric oncology patients in British Columbia: prevalence and reasons for use and nonuse. JClinOncol. 1998;16:1279-1286.
16. Martel D, Bussieres JF,Theoret Y, et al. Use of alternative and complementary therapies in children with cancer. Pediatr Blood Cancer. 2005;44:660-668.
17. Gomez-Martinez R, Tlacuilo-Parra A, Garibaldi-Covarrubias R. Use of complementary and alternative medicine in children with cancer in Occidental,Mexico. Pediatr Blood Cancer. 2007;49:820-823.
18. Langler A, Spix C, Gottschling S, et al. Parents-interview on use of complementary and alternative medicine in pediatric oncology in Germany. Klin Padiatr. 2005;217:357-364.
19. Molassiotis A, Cubbin D. "Thinking outside the box": complementary and alternative therapies use in pediatric oncology patients. Eur J Oncol Nurs. 2004;8:50-60.
20. Grootenhuis MA, Last BF, de Graff-Nijkerk JH, et al. Use of alternative treatment in pediatric oncology. Cancer Nurs. 1998;21:282-288.
21. Yeh CH, Tsai JL, LiW, et al. Use of alternative therapy among pediatric oncology patients in Taiwan. Pediatr Hematol Oncol. 2000;17:55-65.
22. Lim J,WongM, ChanMY, et al. Use of complementary and alternativemedicine in paediatric oncology patients in Singapore. Ann AcadMed Singapore. 2006;35:753-758.
23. Bold J, Leis A. Unconventional therapy use among children with cancer in Saskatchewan. J Pediatr Oncol Nurs. 2001;18:16-25.
24. Friedman T, Slayton WB, Allen LS, et al. Use of alternative therapies for children with cancer. Pediatrics. 1997;100(6):E1.
25. NeuhouserML, Patterson RE, Schwartz SM, et al.Use of alternativemedicine by childrenwith cancer inWashington State. Prev Med. 2001;33:347-354.
26. Fletcher PC, Clarke J.The use of complementary and alternative medicine among pediatric patients. Cancer Nurs. 2004;27:93-99.
27. Loman DG.Theuse of complementary and alternative health care practices among children. J Pediatr Health Care. 2003;17:58-63.
28. Sawyer MG, Gannoni AF, Toogood IR, et al. The use of alternative therapies by children with cancer. Med J Aust. 1994;160:320-322.
29. Spigelblatt L, Laine-AmmaraG, Pless IB, et al.Theuse of alternative medicine by children. Pediatrics. 1994;94:811-814.
30. Malik IA, Khan NA, Khan W. Use of unconventional methods of therapy by cancer patients in Pakistan. Eur J Epidemiol. 2000;16:155-160.
31. Marchetti S, Mazzanti R, Beijnen JH, et al. Concise review: clinical relevance of drug-drug and herb-drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein). Oncologist. 2007;12:927-941.
32. Ernst E. Serious adverse effects of unconventional therapies for children and adolescents: a systematic review of recent evidence. Eur J Pediatr. 2003;162:72-80.
33. Buiatti E, Arniani S, Verdecchia A, et al. Results from a historical survey of the survival of cancer patients given Di Bellamultitherapy. Cancer. 1999;86:2143-2149.